BLUE
2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|
| Lyfgenia | 12,405 | - | - | - |
| Zynteglo | 26,307 | - | - | - |
| Total revenues | 38,712 | 10,612 | 16,101 | 18,573 |
| Cost of product revenue | 12,237 | 11,781 | 28,946 | 25,864 |
| Gross margin | 26,475 | -1,169 | -12,845 | -7,291 |
| Selling, general and administrative | 30,261 | 39,765 | 50,385 | 46,329 |
| Restructuring expenses | 3,100 | 2,811 | - | - |
| Research and development | 17,721 | 23,174 | 25,162 | 25,072 |
| Total operating expenses | 51,082 | 65,750 | 75,547 | 71,401 |
| Loss from operations | -24,607 | -66,919 | -88,392 | -78,692 |
| Interest income | 612 | 1,640 | 2,837 | 2,579 |
| Interest expense | 5,743 | 5,778 | 5,453 | - |
| Other income, net | 769 | 10,191 | 9,636 | 11,165 |
| Interest expense | - | - | - | 4,856 |
| Loss before income taxes | -28,969 | -60,866 | -81,372 | -69,804 |
| Income tax (expense) benefit | 100 | -58 | 21 | - |
| Net loss | -29,069 | -60,808 | -81,393 | -69,804 |
| Total other comprehensive income (loss) | 254 | 611 | -14 | -312 |
| Comprehensive loss | -28,815 | -60,197 | -81,407 | -70,116 |
| Basic eps | -2.98 | -0.31 | -0.42 | -0.36 |
| Diluted eps | -2.98 | -0.31 | -0.42 | -0.36 |
| Basic average shares | 9,751,000 | 193,893,000 | 193,716,000 | 193,151,000 |
| Diluted average shares | 9,751,000 | 193,893,000 | 193,716,000 | 193,151,000 |